{"disease":{"id":"albinism","name":"albinism"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06491615","title":"National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05954416","title":"FARD (RaDiCo Cohort) (RaDiCo-FARD)","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06330324","title":"Reproductive Options in Inherited Skin Diseases","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":650,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT00808106","title":"Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism","phase":"","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT04068961","title":"New Strategies of Genetic Study of Patients With Oculocutaneous Albinism","phase":"","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04495218","title":"NGS Panel of Incomplete Forms of Ocular Albinism","phase":"","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06345976","title":"Functional Impairment in Albinism","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT03959605","title":"Genetic Determinant of Foveolar Hypoplasia in Parents of Albinos Children","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT06330350","title":"Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT04281732","title":"Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT04658381","title":"Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT01663935","title":"Vision Response to Dopamine Replacement","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":true},{"nct_id":"NCT07313618","title":"Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1)","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT01838655","title":"Nitisinone for Type 1B Oculocutaneous Albinism","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":true}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}